Skip to main content
Wenying Qiao on Muck Rack

Wenying Qiao

As seen in: Frontiers, Dove Medical Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Wenying

Contact Wenying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prognostic model for predicting recurrence-free survival in HBV-related hepatocellular carcinoma patients after combined treatment: a multicenter study

|
By Bojun Liu, Xue Yin, Wenying Qiao, Xiaoyan Ding, Caixia Hu
| Frontiers
Abstract Introduction: Hepatocellular carcinoma (HCC) is a lethal malignancy, with hepatitis B virus (HBV) infection as its leading cause in China. Transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) treatment was gradually applied in clinic, but the lack of targeted prognostic tools for this cohort remains a critical issue.
Open in Who Shared Issue with article?

HCC and low Albumin-Bilirubin in TACE Combined with Ablation

|
By Yiqi Xiong, Wenying Qiao, Tingting Mei, Ronghua Jin
| Dove Medical Press
Introduction Hepatocellular carcinoma (HCC) accounts for approximately 90% of liver cancer and is the sixth leading cause of cancer and the fourth leading cause of cancer-related mortality worldwide, which has caused an enormous burden on global health.1,2 Despite the decline in incidence, HCC remains the second most common cancer, with 36000 new cases reported annually.3,4 For HCC patients in the early-stage, curative treatments such as resection, ablation, and liver transplantation are...
Open in Who Shared Issue with article?

Nomogram to Predict Recurrence in Patients with HCC

|
By Wenying Qiao, Yiqi Xiong, Ronghua Jin, Yonghong Zhang
| Dove Medical Press
Back to Journals » Journal of Hepatocellular Carcinoma » Volume 11 Authors Qiao W , Xiong Y, Li K, Jin R, Zhang Y Received 2 April 2024 Accepted for publication 30 May 2024 Published 13 June 2024 Volume 2024:11 Pages 1113—1125 DOI https://doi.org/10.2147/JHC.S465069 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Manal Hassan Wenying Qiao,1– 3,* Yiqi Xiong,1,* Kang Li,4 Ronghua Jin,2,3 Yonghong Zhang1,5...
Open in Who Shared Issue with article?
See all 6 articles